Pharmacokinetics of PP353, a formulation of linezolid for intervertebral disc administration, in patients with chronic low back pain and Modic change Type 1: A first-in-human, Phase 1b, open-label, single-dose study

PP353（一种用于椎间盘给药的利奈唑胺制剂）在慢性腰痛和Modic I型改变患者中的药代动力学：一项首次人体Ib期开放标签单剂量研究